Bergijk E C, Baelde H J, de Heer E, Killen P D, Bruijn J A
Department of Pathology, University of Leiden, The Netherlands.
Exp Nephrol. 1995 Nov-Dec;3(6):338-47.
Glomerulosclerosis is a severe complication of many immunologically mediated kidney diseases and is associated with a poor prognosis with respect to renal function. The aim of this study was to elucidate the role of the extracellular matrix (ECM) in the development of glomerulosclerosis in experimental immune complex glomerulonephritis. Induction of chronic serum sickness by repetitive injections of human IgG into preimmunized Wistar rats leads to the development of immune complex nephritis and glomerulosclerosis. At an early stage of the disease fibrinogen accumulation was observed along the endothelial cells, presumably related to damage of the endothelial lining. mRNA levels for several collagen types, laminin B1 and B2, and fibronectin were increased in both whole-kidney tissue and in isolated glomeruli, but morphological changes were not observed. In situ hybridization experiments demonstrated increased ECM mRNA levels in glomerular and tubular cells. Starting at week 15, glomerular mesangial matrix expansion and thickening of the glomerular basement membrane (GBM) was observed. ECM components were abundantly present. Coagulation factors were not observed at this point. ECM mRNA levels were decreased as compared to week 0, but were still above normal. Focal and segmental end-stage sclerotic lesions developed at weeks 25-30, in which fibronectin and fibrinogen were the major constituents. Other ECM components were found peripherally from these lesions in the remnants of the mesangial matrix and GBM. Sclerotic matrices did not demonstrate an increase of cellular-fibronectin, and other constituents from the circulation were not present in the lesions. Glomerular ECM mRNA was decreased to normal levels. However, a dramatic increase of ECM mRNA expression was observed at sites of inflammatory infiltrate in the perivascular, interstitial, and periglomerular regions. In conclusion, the development of glomerulosclerosis in chronic serum sickness rats is preceded by mesangial matrix expansion in which several ECM components are increasingly expressed. Steady state mRNA levels for these components are increased before morphological changes are detectable. In the final stage there is a specific accumulation of exogenous fibronectin in the glomerular end-stage sclerotic lesions. Simultaneously, an interstitial inflammatory reaction takes place leading to increased ECM production in the tissue surrounding the damaged glomeruli.
肾小球硬化是许多免疫介导性肾脏疾病的严重并发症,且与肾功能预后不良相关。本研究的目的是阐明细胞外基质(ECM)在实验性免疫复合物肾小球肾炎肾小球硬化发展过程中的作用。通过向预先免疫的Wistar大鼠重复注射人IgG诱导慢性血清病,可导致免疫复合物肾炎和肾小球硬化的发生。在疾病早期,观察到沿内皮细胞有纤维蛋白原积聚,推测与内皮细胞损伤有关。在全肾组织和分离的肾小球中,几种胶原类型、层粘连蛋白B1和B2以及纤连蛋白的mRNA水平均升高,但未观察到形态学变化。原位杂交实验表明,肾小球和肾小管细胞中ECM mRNA水平升高。从第15周开始,观察到肾小球系膜基质扩张和肾小球基底膜(GBM)增厚。ECM成分大量存在。此时未观察到凝血因子。与第0周相比,ECM mRNA水平下降,但仍高于正常水平。在第25 - 30周出现局灶性和节段性终末期硬化病变,其中纤连蛋白和纤维蛋白原是主要成分。在这些病变周围的系膜基质和GBM残余中发现了其他ECM成分。硬化基质中未显示细胞纤连蛋白增加,病变中也不存在来自循环的其他成分。肾小球ECM mRNA降至正常水平。然而,在血管周围、间质和肾小球周围区域的炎症浸润部位,观察到ECM mRNA表达显著增加。总之,慢性血清病大鼠肾小球硬化的发展之前是系膜基质扩张,其中几种ECM成分表达增加。在可检测到形态学变化之前,这些成分的稳态mRNA水平就已升高。在终末期,外源性纤连蛋白在肾小球终末期硬化病变中特异性积聚。同时,发生间质炎症反应,导致受损肾小球周围组织中ECM产生增加。